IndraLab

Statements


STAMBP inhibits subclone EL4-6.1. 1 / 1
| 1

reach
"In addition, Mugridge et al. (1 l) demonstrated that aMSH (11-13) potently and selectively reduced [" I]-IL-1 binding to the IL-1 type I (80 kDa) receptor binding, T-cell subclone EL4-6.1."